10x Genomics to Participate in Upcoming June Investor Conferences

NEXT STORY
PDS Biotech to Host Company Conference Call Following Oral Presentation of PDS0101 Data at 2021 ASCO Annual Meeting
PREV STORY
BeyondSpring Presents Phase 1 Data on the Anti-Cancer Effect of Plinabulin in Combination with Checkpoint Inhibitors in SCLC at the American Society of Clinical Oncology (ASCO) Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Teladoc Health Reports First-Quarter 2021 Results

author_avatar
NASDAQ Market News

Loxo Oncology Announces Second Quarter 2017 Financial Results

– Larotrectinib NDA Submission on Track for Year End 2017 / Early 2018 – ...

author_avatar
NASDAQ Market News

While ElsaLys continues to work on the filing of marketing approval in Europe and the U.S. for inolimomab, the company confirms the renew of its cohort ATU in France and compassionate use programs submissions in several other countries

author_avatar
NASDAQ Market News